ArticleBiological psychiatry. Cognitive neuroscience and neuroimaging2026
Major Depressive Disorder and Serum Inflammatory Biomarkers as Predictors of Reward-Processing Dysfunction in an American Indian Sample.
Article in Biological psychiatry. Cognitive neuroscience and neuroimaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
backgroundAmerican Indians (AIs) experience chronic stressors that may be associated with disproportionate prevalence rates of major depressive disorder (MDD). Stress affects mental health through increased inflammatory processes and has been associated with increased risk of MDD and disruptions to reward processing. In this study, we investigated the role of inflammation in reward-processing disruptions among AI individuals with lifetime MDD, a population at heightened risk due to chronic stressors.
methodsParticipants (N = 73) completed a monetary incentive delay task during simultaneous electroencephalography and functional magnetic resonance imaging. Blood samples were analyzed for proinflammatory (tumor necrosis factor [TNF], interleukin 6 [IL-6], C-reactive protein [CRP]) and anti-inflammatory (IL-10) biomarkers. Depression severity was assessed using the Patient-Reported Outcomes Measurement Information System (PROMIS) Depression scale. Covariates were included and assessed using self-report measures.
resultsRegression analyses revealed that elevated TNF concentrations and sex were associated with reduced activation across subregions of the basal ganglia during gain anticipation. Similarly, TNF and CRP concentrations, as well as medication, were associated with reduced activation within basal ganglia subregions across loss anticipation. IL-10, IL-6, and P300 showed limited predictive value for neural responses.
conclusionsThese findings suggest that inflammation may contribute to reward-processing disruptions by impairing striatal function in a sample with lifetime MDD. The observed associations underscore the importance of inflammation's potential role in and association with the pathophysiology of MDD, particularly in contexts of chronic stress. This study highlights the need to address the disproportionate mental health burden in AI communities through a biopsychosocial approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.